Genpharmasec Board Approves Unaudited Q1 FY27 Results

Genpharmasec Limited announced that its Board of Directors, in a meeting held on August 11, 2026, has considered and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were reviewed by the Audit Committee and are accompanied by a Limited Review Report from the independent auditor, Bilimoria Mehta & Co. The board meeting commenced at 3:00 p.m. and concluded at 3:50 p.m. The company has submitted these results as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.